Salicylate
ApprovedSmall molecule
Salicylate is one of 20 small molecule programs targeting Keratosis. It is currently in Approved.
2
Indications
2
Total Trials
0
Active Trials
19
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
23 competitors in Plantar Wart
#DrugCompanyPhaseTrials
1Zovirax
BBp Consulting, Inc
Approved
Aldara
BBausch Health Americas, Inc.
Approved
Salicylate
AAssistance Publique - Hôpitaux de Paris
Approved
CRYOTHERAPY
AAssistance Publique - Hôpitaux de Paris
Approved
Inomax
MMallinckrodt
Phase 2
Salicylic Acid
HHadassah Medical Organization
Phase 3
Blenoxane
Bristol-Myers SquibbPreclinical
Potassium Hydroxide
SSohag University
Phase 3
Intralesional Acyclovir
RRiphah International University
Phase 3
Xylocaine
CCitius Pharmaceuticals, Inc.
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Salicylate. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details